Works Cited

1. Grinde B, Olsen I. The role of viruses in oral disease. J Oral Microbiol. 2010;2:2127.

2. Aas JA, Paster BJ, Stokes LN, Olsen I, Dewhirst FE. Defining the normal bacterial flora of the oral cavity. J Clin Microbiol. 2005;43(11): 5721-5732.

3. Krishnan PA. Fungal infections of the oral mucosa. Indian J Dental Res. 2012;23(5):650-659.

4. Fabian TK, Fejerdy P, Csermely P. Saliva in health and disease. In: Begley TP (ed). Wiley Encyclopedia of Chemical Biology. Hoboken, NJ: John Wiley and Sons, Inc; 2008: 1-9.

5. Brandtzaeg P. Do salivary antibodies reliably reflect both mucosal and systemic immunity? Ann NY Acad Sci. 2007;1098:288-311.

6. Brodgen KA. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol. 2005;3(3):238-250.

7. Li XS, Sun JN, Okamoto-Shibayama K, Edgerton M. Candida albicans cell wall Ssa proteins bind and facilitate import of salivary histatin 5 required for toxicity. J Biol Chem. 2006;281(32):22453-22463.

8. Fabian TK, Hermann P, Beck A, Fejerdy P, Fabian G. Salivary defense proteins: their network and role in innate and acquired oral immunity. Int J Mol Sci. 2012;13(4):4295-4320.

9. Gregoire C. How are odontogenic infections best managed? J Can Dent Assoc. 2010;76:a37.

10. Harp JR, Ellis E III, Tucker MR. Contemporary Oral and Maxillofacial Surgery. 6th ed. St. Louis, MO: Mosby; 2014.

11. Miliro M, Ghali GE, Larsen PE, Waite P. Peterson's Principles of Oral and Maxillofacial Surgery. 3rd ed. Shelton, CT: People's Medical Publishing House; 2012.

12. Dennis MJ. Treating odontogenic infections: an update for dental professionals. J Mich Dent Assoc. 2006;8(11):20-25.

13. Sequra-Eqea JJ, Martin-Gonzalez J, Jimenez-Sanchez MDC, Crespo-Gallardo I, Sauco-Marquez JJ, Velasco-Ortega E. Worldwide pattern of antibiotic prescription in endodontic infections. Int Dent J. 2017;[Epub ahead of print].

14. Munoz-Price LS, Jacoby GA. Extended-Spectrum Beta-Lactamases. Available at http://www.uptodate.com/contents/extended-spectrum-beta-lactamases. Last accessed May 16, 2017.

15. Drwaz SM, Bonomo RA. Three decades of beta-lactamase inhibitors. Clin Microbiol Rev. 2010;23(1):160-201.

16. Cotter G, Kavanagh K. Adherence mechanism of Candida albicans. Br J Biomed Sci. 2000;57(3):241-249.

17. Hoyer LL. The ALS gene family of Candida albicans. Trends Microbiol. 2001;9(4):176-180.

18. Staab JF, Bradway SD, Fidel PL, Sundstrom P. Adhesive and mammalian transglutaminase substrate properties of Candida albicans Hwp1. Science. 1999;283(5407):1535-1538.

19. Raju SB, Rajappa S. Isolation and identification of Candida from the oral cavity. ISRNDent. 2011;2011:487921.

20. Marsh PD, Martin M. Oral Microbiology. Edinburgh: Churchill Livingstone; 2009.

21. Slots J. Oral viral infections of adults. Periodontology2009;49:60-86.

22. Akhter K. Cytomegalovirus. Available at http://emedicine.medscape.com/article/215702-overview. Last accessed May 16, 2017.

23. Pellett PE, Roizman B. The family Herpesviridae: a brief introduction. In: Knipe DM, Howley PM (eds). Fields Virology. 6th ed. Philadelphia, PA: Lippincott, Williams and Wilkins; 2013: 1802-1822.

24. Hobbs CG, Sterne JA, Bailey M, Heyderman RS, Birchall MA, Thomas SJ. Human papillomavirus and head and neck cancer: a systematic review and meta-analysis. Clin Otolaryngol. 2006:31(4):259-266.

25. Howley PM, Schiler JT, Lowy DR. Papillomaviruses. In: Knipe DM, Howley PM (eds). Fields Virology. 6th ed. Philadelphia: Lipincott, Williams and Wilkins; 2013: 1662-1703.

26. National Institutes of Health. Dental Caries (Tooth Decay). Available at https://www.nidcr.nih.gov/DataStatistics/FindDataByTopic/DentalCaries/. Last accessed May 16, 2017.

27. Piris-Lopez R, Aguilar L, Gimenez MJ. Management of odontogenic infections of pulpal and periodontal origin. Med Oral PatolOral Cir Bucal. 2007;12(2):e154-e159.

28. Robertson D, Smith A.J. The microbiology of the acute dental abscess. J Med Microbiol. 2009;58(2):155-162.

29. Patel PV, Kumar SG, Patel A. Periodontal abscess: a review. J Clin Diagnostic Res. 2011;5(2):404-409.

30. Jaramillo A, Arce RM, Herrera D, Betancourth M, Botero JE, Contreras A. Clinical and microbiological characterization of periodontal abscesses. J Clin Periodontol. 2005;32(12):1213-1218.

31. Herrera D, Roldan S, Gonzalez I, Sanz M. The periodontal abscess (I): clinical and microbiological findings. J Clin Periodontol. 2000;27(6):387-394.

32. Prato-Pini G, Magnani C, Rotundo R. Treatment of acute periodontal abscesses using the biofilm decontamination approach: a case report study. Int J Periodontics Restorative Dent. 2016;36(1):55-63.

33. Topazian RG, Goldberg MH, Hupp JR. Oral and Maxillofacial Infections. 4th ed. New York, NY: WB Saunders Company; 2002.

34. Centers for Disease Control and Prevention. HIV/AIDS: Terms, Definitions, and Calculations Used in CDC HIV Surveillance Publications. Available at http://www.cdc.gov/hiv/statistics/recommendations/terms.html. Last accessed May 16, 2017.

35. Tyring S. Mucosal Immunology and Virology. London: Springer-Verlag; 2006.

36. Portela MB, Cerqueeira DF, Soares RMA, Castro GF. Candida spp. in linear gingival erythema lesions in HIV-infected children: reports of six cases. Int J Science Dentistry. 2012;1(37):51-55.

37. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol. 1999;4(1):1-6.

38. Rutgers. HIV and Oral Healthcare. Available at http://ccoe.rbhs.rutgers.edu/online/ARCHIVE/14HC02/. Last accessed May 16, 2017.

39. Todescan S, Nizar R. Managing patients with necrotizing ulcerative periodontitis. J Can Dent Assoc. 2013;79:d44.

40. Feller L, Lemmer J. Necrotizing gingivitis as it relates to HIV infection: a review of the literature. Perio Pract Today. 2005;2(1): 31-37.

41. Patton LL. The ADA Practical Guide to Patients with Medical Conditions. 2nd. Hoboken, NJ: Wiley & Sons, Inc.; 2016.

42. Laskin DM. Clinician's Handbook of Oral and Maxillofacial Surgery. Hanover Park, IL: Quintessence Publishing Com Inc; 2010.

43. American Dental Association. ADA/PDR Guide to Dental Therapeutics. 5th ed. Montvale, NJ: Physicians' Desk Reference, Inc.; 2009.

44. Wynn RL, Meiller TF, Crossley HL. Drug Information Handbook for Dentistry. 22nd ed. Hudson, OH: Lexicomp; 2016.

45. Chunduri NS, Madasu K, Goteci VR, Karpe T, Reddy H. Evaluation of bacterial spectrum or orofacial infections and their antibiotic susceptibility. Ann Maxillofac Surg. 2012;2(1):46-50.

46. Geddes AM, Klugman KP, Rolinson GN. Introduction: historical perspective and development of amoxicillin/clavulanate.Int J Antimicrob Agents. 2007;30(2):S109-S112.

47. Newman MG, van Winkelhoff AJ. Antibiotic and Antimicrobial Use in Dental Practice. 2nd ed. Carol Stream, IL: Quintessence Publishing Co, Inc.; 2001.

48. Little JW, Falace Donald L, Miller CS, Rhodus NL. Dental Management of the Medically Compromised Patient. 8th ed. St. Louis, MO: Mosby Elsevier; 2012.

49. eMedExpert. Azithromycin (Zithromax). Available at http://www.emedexpert.com/facts/azithromycin-facts.shtml. Last accessed May 16, 2017.

50. Scully C. Mucosal Candidiasis. Available at http://emedicine.medscape.com/article/1075227-overview. Last accessed May 16, 2017.

51. Reichart PA, Samaranayake LP and Philipsen HP. Pathology and clinical correlates in oral candidiasis and its variants: a review. Oral Dis. 2000;6:85-91.

52. Harding A. Gentian Violet as Effective as Nystatin for Oral Candidiasis in AIDS. Available at http://www.managedhealthcareconnect.com/content/gentian-violet-effective-nystatin-oral-candidiasis-aids. Last accessed May 16, 2017.

53. Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62(4):e1-e50.

54. Krcmery V, Barnes AJ. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J Hosp Infect 2002;50(4):243-260.

55. Scully C. Noncandidal Fungal Infections of the Mouth. Available at http://emedicine.medscape.com/article/1077685-overview. Last accessed May 16, 2017.

56. Milian Masanet A, Bagan Sebastian JV, Riera Grimalt J, Lloria de Miguel E, Jimenez Soriano Y. Sinus aspergillosis after an endodontic treatment: presentation of a clinical case. Acta Otorrinolaringol Esp. 1998;49(5):408-410.

57. MedlinePlus. Herpes – Oral. Available at https://medlineplus.gov/ency/article/000606.htm. Last accessed May 16, 2017.

58. Ayoade FO. Herpes Simplex. Available at http://emedicine.medscape.com/article/218580-overview#a4. Last accessed May 16, 2017.

59. Dronen SC. Herpetic Whitlow. Available at http://emedicine.medscape.com/article/788056-overview. Last accessed May 16, 2017.

60. Anderson WE. Varicella-Zoster Virus. Available at http://emedicine.medscape.com/article/231927-overview. Last accessed May 16, 2017.

61. Centers for Disease Control and Prevention. Shingles (Herpes Zoster): Prevention and Treatment. Available at http://www.cdc.gov/shingles/about/prevention-treatment.html. Last accessed May 16, 2017.

62. Cade JE. Hairy Leukoplakia. Available at http://emedicine.medscape.com/article/279269-overview. Last accessed May 16, 2017.

63. zur Hausen H. Papillomaviruses in human cancers. Proc Assoc Am Physicians. 1999;111(6):581-587.

64. Eversole LR. Papillary lesions of the oral cavity: relationship to human papillomaviruses. J Calif Dent Assoc. 2000;28(12):922-927.

65. Scully C, Epstein J, Porter S, Cox M. Viruses and chronic disorders involving the human oral mucosa. Oral Surg Oral Med Oral Pathol. 1991;72(5):537-544.

66. Ghadishah D. Genital Warts. Available at http://emedicine.medscape.com/article/763014-overview. Last accessed May 16, 2017.

67. Kellokoski J, Syrjanen S, Syrjanen K, Yliskoski M. Oral mucosal changes in women with genital HPV infection. J Oral Pathol Med. 1990;19(3):142-148.

68. Silverman S Jr. Color Atlas of Oral Manifestations of AIDS. 2nd ed. St. Louis, MO: Mosby, Inc.; 1996.

69. Eversole LR, Laipis PJ. Oral squamous papillomas: detection of HPV DNA by in situ hybridization. Oral Surg Oral Med Oral Pathol. 1988;65(5):545-550.

70. Scully C, Flint SR, Porter SR. Oral Diseases. 2nd ed. St. Louis, MO: Mosby, Inc.; 1996.

71. Ghalayani P, Tavakoli P, Eftekhari M, Haghighi MA. Oral focal epithelial hyperplasia: report of three cases. Turk Patoloji Derg. 2015;31(1):880-83.

72. Harris AM, van Wyk CW. Heck's disease (focal epithelial hyperplasia): a longitudinal study. Community Dent Oral Epidemiol. 1993;21(2):82-85.

73. Padayachee A, van Wyk CW. Human papillomavirus (HPV) DNA in focal epithelial hyperplasia by in situ hybridization. J Oral Pathol Med. 1991;20(5):210-214.

74. DermNet New Zealand. Focal Epithelial Hyperplasia. Available at https://www.dermnetnz.org/topics/focal-epithelial-hyperplasia. Last accessed May 16, 2017.


Copyright © 2017 NetCE, P.O. Box 997571, Sacramento, CA 95899-7571
Mention of commercial products does not indicate endorsement.